+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro transport of methotrexate by Drosophila Multidrug Resistance-associated Protein



In vitro transport of methotrexate by Drosophila Multidrug Resistance-associated Protein



Plos One 13(10): E0205657



Methotrexate (MTX) is a widely used chemotherapeutic agent, immune suppressant and antimalarial drug. It is a substrate of several human ABC proteins that confer multidrug resistance to cancer cells and determine compartmentalization of a wide range of physiological metabolites and endo or xenobiotics, by their primary active transport across biological membranes. The substrate specificity and tissue distribution of these promiscuous human ABC transporters show a high degree of redundancy, providing robustness to these key physiological and pharmacological processes, such as the elimination of toxins, e.g. methotrexate from the body. A similar network of proteins capable of transporting methotrexate has been recently suggested to exist in Drosophila melanogaster. One of the key players of this putative network is Drosophila Multidrug-resistance Associated Protein (DMRP). DMRP has been shown to be a highly active and promiscuous ABC transporter, capable of transporting various organic anions. Here we provide the first direct evidence that DMRP, expressed alone in a heterologous system lacking other, potentially functionally overlapping D. melanogaster organic anion transporters, is indeed able to transport methotrexate. Our in vitro results support the hypothesized but debated role of DMRP in in vivo methotrexate excretion.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065824860

Download citation: RISBibTeXText

PMID: 30312334

DOI: 10.1371/journal.pone.0205657


Related references

Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Research 62(11): 3144-3150, 2002

Transport of methotrexate and folates by multidrug resistance protein 3 and MRP1 Effect of polyglutamylation on MTX transport. Cancer Research 61(19): 7225-7232, October 1, 2001

Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Research 61(19): 7225-7232, 2001

Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 285(3): G602-G610, 2003

The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models. Molecular Pharmacology 71(1): 240-249, 2006

Multidrug resistance modulation by the taxane derivatives IDN-5109 and tRA96023 Effects on P-glycoprotein -, multidrug resistance protein -, and breast cancer resistance protein - mediated drug transport. Proceedings of the American Association for Cancer Research Annual Meeting 43: 950, 2002

In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2. Molecular Cancer Therapeutics 6(12 Pt 1): 3307-3313, 2007

Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. Journal of Pharmacology and Experimental Therapeutics 320(1): 229-235, 2006

Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. Journal of Biological Chemistry 276(41): 38108-38114, 2001

Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function. Molecular Medicine 20: 390-399, 2015

Increased Systemic Exposure of Methotrexate by a Polyphenol-Rich Herb via Modulation on Efflux Transporters Multidrug Resistance-Associated Protein 2 and Breast Cancer Resistance Protein. Journal of Pharmaceutical Sciences 105(1): 343-349, 2016

Impact of abcc2 [multidrug resistance-associated protein (MRP) 2], abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexate. Drug Metabolism and Disposition: the Biological Fate of Chemicals 39(8): 1338-1344, 2011

Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats. Cancer Science 97(11): 1260-1266, 2006

Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. International Journal of Hematology 86(2): 166-173, 2007

Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3. British Journal of Cancer 75(2): 161-168, 1997